Stoneridge Investment Partners’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-18,684
| Closed | -$26K | – | 287 |
|
|
2017
Q3 | $26K | Hold |
18,684
| – | – | ﹤0.01% | 236 |
|
|
2017
Q2 | $28K | Sell |
18,684
-38,722
| -67% | -$58K | ﹤0.01% | 249 |
|
|
2017
Q1 | $148K | Buy |
57,406
+16,399
| +40% | +$42.3K | 0.02% | 294 |
|
|
2016
Q4 | $105K | Hold |
41,007
| – | – | 0.01% | 280 |
|
|
2016
Q3 | $127K | Sell |
41,007
-192
| -0.5% | -$595 | 0.02% | 257 |
|
|
2016
Q2 | $132K | Hold |
41,199
| – | – | 0.02% | 273 |
|
|
2016
Q1 | $128K | Sell |
41,199
-15,556
| -27% | -$48.3K | 0.02% | 279 |
|
|
2015
Q4 | $228K | Sell |
56,755
-7,637
| -12% | -$30.7K | 0.03% | 254 |
|
|
2015
Q3 | $295K | Sell |
64,392
-800
| -1% | -$3.67K | 0.04% | 240 |
|
|
2015
Q2 | $338K | Buy |
65,192
+18,465
| +40% | +$95.7K | 0.04% | 236 |
|
|
2015
Q1 | $293K | Buy |
46,727
+1,069
| +2% | +$6.7K | 0.03% | 234 |
|
|
2014
Q4 | $287K | Buy |
+45,658
| New | +$287K | 0.04% | 221 |
|
|
2014
Q2 | – | Sell |
-43,136
| Closed | -$1.03M | – | 262 |
|
|
2014
Q1 | $1.03M | Buy |
+43,136
| New | +$1.03M | 0.2% | 90 |
|